연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2023년 | 2022년 | 2021년 | 2020년 | 2019년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 173편 | 163편 | 184편 | 135편 | 144편 |
| 공동 | 120편 | 115편 | 136편 | 168편 | 167편 | |
| 합계 | 293편 | 278편 | 320편 | 303편 | 311편 | |
2281. Characteristics of Waldenström Macroglobulinemia in Korean Patients According to Mutational Status of MYD88 and CXCR4: Analysis Using Ultra-Deep Sequencing.
Shin DW1, Kim SM2, Kim JA3, Park HS1, Hwang SM4, Im K2, Kim S5, Kim J6, Kwon S6, Yoon SS7, Lee DS8.
Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):e496-e505. doi: 10.1016/j.clml.2019.03.009. Epub 2019 Mar 15.
Link
2280. Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte.
Choi HS1, Choi Q2, Kim JA3, Im KO4, Park SN4, Park Y5, Shin HY4,6, Kang HJ4,6, Kook H7, Kim SY8, Kim SJ9, Kim I10, Kim JY11, Kim H12, Park KD4,6, Park KB13, Park M14, Park SK15, Park ES16, Park JA17, Park JE18, Park JK19, Baek HJ7, Seo JH20, Shim YJ21, Ahn HS6, Yoo KH22, Yoon HS23, Won YW24, Lee KS11, Lee KC25, Lee MJ26, Lee SA27, Lee JA28, Lee JM29, Lee JH30, Lee JW22, Lim YT20, Jung HJ18, Chueh HW31, Choi EJ32, Jung HL33, Kim JH34, Lee DS35; Hereditary Hemolytic Anemia Working Party of the Kor
Orphanet J Rare Dis. 2019 May 23;14(1):114. doi: 10.1186/s13023-019-1070-0.
Link
2279. Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia.
Hwang SM1, Kim SM2, Nam Y1, Kim J3, Kim S4, Ahn YO2, Park Y5, Yoon SS6, Shin S7, Kwon S3, Lee DS8.
Leuk Res. 2019 Sep;84:106190. doi: 10.1016/j.leukres.2019.106190. Epub 2019 Jul 12.
Link
2278. Replicative senescence of hematopoietic cells in patients with idiopathic cytopenia of undetermined significance.
Shin DY1, Park JK2, Li CC3, Park HS4, Moon SY5, Kim SM6, Im K6, Chang YH7, Yoon SS8, Lee DS9.
Leuk Res. 2019 Apr;79:22-26. doi: 10.1016/j.leukres.2019.02.004. Epub 2019 Feb 18.
Link
2277. Prevalence of germline predisposition gene mutations in pediatric acute myeloid leukemia: Genetic background of pediatric AML.
Jeong D1, Lee DS2, Kim N1, Choi S3, Kim K3, Kim SM4, Im K4, Park HS5, Yun J1, Lim KM4, Park KS6, Kang HJ7, Ahn YO4, Hwang SM8.
Leuk Res. 2019 Oct;85:106210. doi: 10.1016/j.leukres.2019.106210. Epub 2019 Aug 12.
Link
2276. Expression of SLC5A5 in Circulating Tumor Cells May Distinguish Follicular Thyroid Carcinomas from Adenomas: Implications for Blood-Based Preoperative Diagnosis.
Jee HG, Kim BA, Kim M, Yu HW, Choi JY, Kim SJ, Lee KE.
Journal of clinical medicine. 2019 Feb;8(2):257.
Link
2275. Prognostic Impact of Pregnancy in Korean Patients with Breast Cancer.
Choi M1, Han J2, Yang BR2, Jang MJ2, Kim M1,3, Kim TY1,3, Im SA1,3, Lee HB4, Moon HG4, Han W4, Noh DY4, Lee KH5,3.
Oncologist. 2019 Dec;24(12):e1268-e1276. doi: 10.1634/theoncologist.2019-0167. Epub 2019 Jul 2.
Link
2274. Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients.
Kim JY1,2, Lee DW3, Lee KH4,5,6, Min A1,2, Ryu HS7, Lee HB1,8, Moon HG1,8, Kim TY1,2,3, Han SW1,2,3, Oh DY1,2,3, Han W1,8, Park IA7, Noh DY1,8, Im SA1,2,3, Kim S9.
Breast Cancer Res Treat. 2019 Jul;176(2):453-460. doi: 10.1007/s10549-019-05249-1. Epub 2019 Apr 26.
Link
2273. Immune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I-III breast cancer patients.
Lee DW1, Ryu HS2, Jin MS3, Lee KH4,5,6, Suh KJ7,8, Youk J1, Kim JY7,9, Min A7,9, Lee HB7,10, Moon HG7,10, Kim TY1,7,9, Han SW1,7,9, Oh DY1,7,9, Han W7,10, Park IA2, Noh DY7,10, Im SA11,12,13.
Br J Cancer. 2019 Jul;121(3):230-236. doi: 10.1038/s41416-019-0511-9. Epub 2019 Jul 11.
Link
2272. Prognostic effects of abnormal DNA damage response protein expression in breast cancer.
Suh KJ1,2, Ryu HS3,4, Lee KH5,6, Kim H3, Min A4, Kim TY4,7, Yang Y1,8, Lee HB4,9, Moon HG4,9, Han SW4,7, Oh DY1,4,7, Han W4,9, Park IA3,4, Noh DY4,9, Im SA10,11,12.
Breast Cancer Res Treat. 2019 May;175(1):117-127. doi: 10.1007/s10549-019-05128-9. Epub 2019 Jan 22.
Link